United States · Bill · HR
H.R. 918 (109th)
Medicare Prescription Drug Cost Containment Act of 2005
Introduced
17 February 2005
Last action
14 March 2005 · Referred
Status
Referred to the Subcommittee on Health.
Sponsors
Sen. Flake, Jeff [R-AZ], Rep. Paul, Ron [R-TX-14], Rep. Burton, Dan [R-IN-5], Rep. Wamp, Zach [R-TN-3], Rep. Miller, Jeff [R-FL-1], Rep. McHenry, Patrick T. [R-NC-10], Rep. Culberson, John Abney [R-TX-7], Rep. Barrett, J. Gresham [R-SC-3], Rep. Garrett, Scott [R-NJ-5], Rep. Feeney, Tom [R-FL-24]
Subjects
Healthcare, Taxation, Budget
Source updated
15 August 2025
Healthcare · Taxation · Budget
Summary
Medicare Prescription Drug Cost Containment Act of 2005 - Directs the Secretary of Health and Human Services, on the same date on which the President submits a budget to Congress, to submit to Congress a determination as to whether there is projected to be excess general revenue Medicare prescription drug funding for the fiscal year for which the budget is submitted. States that, if there is an affirmative determination, it shall be treated as a Medicare part D (Voluntary Prescription Drug Benefit Program) funding warning in the fiscal year during which the determination is submitted to Congress. Amends Federal money and finance law, as amended by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, to direct the President to submit to Congress, within 15 days after the budget submission, proposed legislation to respond to such a Medicare part D funding warning. States that such requirement shall not apply if, during the year in which the warning is made, legislation is enacted which eliminates excess general revenue Medicare funding for the period beginning with the fiscal year for which the determination is made and ending on September 30, 2013. Expresses the sense of Congress that any such submitted legislation should be designed to eliminate excess general revenue Medicare funding for such period. Sets out the special procedures for House and Senate consideration of the President's legislative proposal in response to such a warning.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
17 February 2005
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
17 February 2005
Introduced
Sponsor introductory remarks on measure. (CR H757-758)
Source: IntroReferral
17 February 2005
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
17 February 2005
Introduced
Introduced in House
Source: IntroReferral
17 February 2005
Introduced
Introduced in House
Source: IntroReferral
3 March 2005
Referred
Referred to the Subcommittee on Health.
Source: Committee
14 March 2005
Referred
Referred to the Subcommittee on Health.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 17 February 2005 · Download file
Documents
3 official files
Introduced in House (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 17 February 2005
Introduced in House (PDF)
Introduced in House · EN · 17 February 2005
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 17 February 2005
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Sen. Flake, Jeff [R-AZ] · R · Sponsor
- Rep. Paul, Ron [R-TX-14] · R · Sponsor
- Rep. Burton, Dan [R-IN-5] · R · Sponsor
- Rep. Wamp, Zach [R-TN-3] · R · Sponsor
- Rep. Miller, Jeff [R-FL-1] · R · Sponsor
- Rep. McHenry, Patrick T. [R-NC-10] · R · Cosponsor
- Rep. Culberson, John Abney [R-TX-7] · R · Cosponsor
- Rep. Barrett, J. Gresham [R-SC-3] · R · Cosponsor
- Rep. Garrett, Scott [R-NJ-5] · R · Cosponsor
- Rep. Feeney, Tom [R-FL-24] · R · Cosponsor
- · hsif00 · Standing
- · hswm00 · Standing
- · hsru00 · Standing
Related records
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/109th-congress/house-bill/918
- Open data entity: https://api.congress.gov/v3/bill/109/hr/918
- us · 109-hr-918 · source updated 15 August 2025